Attovia Therapeutics (ATTO) Financials: Revenue & Earnings

ATTO price $15.10 +0.10 +0.64%

Ticker
ATTO
Price
$15.10
Change
+0.10 +0.64%
Market cap ?
$689.14M
Sector
Healthcare
Industry
Biotechnology

Fair value

ATTO fair value Not meaningful. Price $15.10.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Not meaningful

Compare ATTO

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-12-02—-0.56—450.00K
2026-09-02-4.88-0.65450.00K316.67K
2026-07-14-0.73———

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-08-06WALSH COLINBuy500.00K$17.008.50M
2026-08-06WALSH COLINBuy478.50K——
2026-08-06WALSH COLINBuy1.96M——
2026-08-06WALSH COLINSell4.45M——
2026-08-06WALSH COLINSell18.18M——
2026-08-06GOLDMAN SACHS GROUP INCBuy500.00K$17.008.50M
2026-08-06GOLDMAN SACHS GROUP INCBuy478.50K——
2026-08-06GOLDMAN SACHS GROUP INCBuy1.96M——
2026-08-06GOLDMAN SACHS GROUP INCSell18.18M——
2026-08-06GOLDMAN SACHS GROUP INCSell4.45M——
2026-08-06WALSH COLINBuy500.00K$17.008.50M
2026-08-06WALSH COLINBuy478.50K——
2026-08-06WALSH COLINBuy1.96M——
2026-08-06WALSH COLINSell18.18M——
2026-08-06WALSH COLINSell4.45M——
2026-08-06GOLDMAN SACHS GROUP INCBuy500.00K$17.008.50M
2026-08-06GOLDMAN SACHS GROUP INCBuy478.50K——
2026-08-06GOLDMAN SACHS GROUP INCBuy1.96M——
2026-08-06GOLDMAN SACHS GROUP INCSell18.18M——
2026-08-06GOLDMAN SACHS GROUP INCSell4.45M——
2026-08-06Deep Track Biotechnology Master Fund, Ltd.Buy1.96M——
2026-08-06Deep Track Biotechnology Master Fund, Ltd.Sell18.18M——
2026-08-06venBio Global Strategic Fund IV, L.P.Buy382.35K$17.006.50M
2026-08-06venBio Global Strategic Fund IV, L.P.Buy665.15K——
2026-08-06venBio Global Strategic Fund IV, L.P.Buy822.00K——
2026-08-06venBio Global Strategic Fund IV, L.P.Buy2.31M——
2026-08-06venBio Global Strategic Fund IV, L.P.Sell6.18M——
2026-08-06venBio Global Strategic Fund IV, L.P.Sell21.48M——
2026-08-06venBio Global Strategic Fund IV, L.P.Sell7.64M——
2026-08-06Redmile Group, LLCBuy400.00K$17.006.80M
2026-08-06Redmile Group, LLCBuy200.00K$17.003.40M
2026-08-06Redmile Group, LLCBuy782.85K——
2026-08-06Redmile Group, LLCSell782.85K——
2026-08-06SanofiBuy300.00K$17.005.10M
2026-08-06SanofiBuy782.86K——
2026-08-06SanofiSell782.86K——
2026-08-06Frazier Life Sciences XI, L.P.Buy588.24K$17.0010.00M
2026-08-06Frazier Life Sciences XI, L.P.Buy961.32K——
2026-08-06Frazier Life Sciences XI, L.P.Buy1.19M——
2026-08-06Frazier Life Sciences XI, L.P.Buy1.59M——
2026-08-06Frazier Life Sciences XI, L.P.Buy1.75M——
2026-08-06Frazier Life Sciences XI, L.P.Sell16.25M——
2026-08-06Frazier Life Sciences XI, L.P.Sell14.77M——
2026-08-06Frazier Life Sciences XI, L.P.Sell11.05M——
2026-08-06Frazier Life Sciences XI, L.P.Sell8.93M——
2026-08-05WALSH COLINBuy5.74K$21.22121.89K
2026-08-05WALSH COLINBuy11.40K$21.27242.44K
2026-08-05WALSH COLINBuy45.59K$21.27969.66K
2026-08-05WALSH COLINBuy85.00K$21.001.78M
2026-08-05WALSH COLINSell988$22.0321.77K
2026-08-05WALSH COLINSell447$21.879.78K
2026-08-05WALSH COLINSell1.33K$22.0329.34K
2026-08-05WALSH COLINSell200$22.054.41K
2026-08-05WALSH COLINSell1.56K$22.0634.33K
2026-08-05WALSH COLINSell3.40K$22.0274.91K
2026-08-05WALSH COLINSell200$22.104.42K
2026-08-05WALSH COLINSell480$21.5510.34K
2026-08-05WALSH COLINSell100$22.112.21K
2026-08-05WALSH COLINSell753$21.9716.54K
2026-08-05WALSH COLINSell672$22.0214.80K
2026-08-05WALSH COLINSell6.97K$22.03153.55K
2026-08-05WALSH COLINSell400$22.028.81K
2026-08-05WALSH COLINSell1.18K$21.8425.77K
2026-08-05WALSH COLINSell1.04K$22.0522.93K
2026-08-05WALSH COLINSell300$20.846.25K
2026-08-05WALSH COLINSell443$21.789.65K
2026-08-05WALSH COLINSell200$22.054.41K
2026-08-05WALSH COLINSell700$22.0715.45K
2026-08-05WALSH COLINSell1.16K$22.1925.81K
2026-08-05WALSH COLINSell100$21.992.20K
2026-08-05WALSH COLINSell6.76K$21.61146.15K
2026-08-05WALSH COLINBuy11.49K$21.22243.78K
2026-08-05WALSH COLINBuy28.72K$21.22609.37K
2026-08-05WALSH COLINBuy2.87K$21.2260.94K
2026-08-05WALSH COLINSell76.42K$21.041.61M
2026-08-05GOLDMAN SACHS GROUP INCBuy5.74K$21.22121.89K
2026-08-05GOLDMAN SACHS GROUP INCBuy11.40K$21.27242.44K
2026-08-05GOLDMAN SACHS GROUP INCBuy45.59K$21.27969.66K
2026-08-05GOLDMAN SACHS GROUP INCBuy85.00K$21.001.78M
2026-08-05GOLDMAN SACHS GROUP INCSell988$22.0321.77K
2026-08-05GOLDMAN SACHS GROUP INCSell447$21.879.78K
2026-08-05GOLDMAN SACHS GROUP INCSell1.33K$22.0329.34K
2026-08-05GOLDMAN SACHS GROUP INCSell200$22.054.41K
2026-08-05GOLDMAN SACHS GROUP INCSell1.56K$22.0634.33K
2026-08-05GOLDMAN SACHS GROUP INCSell3.40K$22.0274.91K
2026-08-05GOLDMAN SACHS GROUP INCSell200$22.104.42K
2026-08-05GOLDMAN SACHS GROUP INCSell480$21.5510.34K
2026-08-05GOLDMAN SACHS GROUP INCSell100$22.112.21K
2026-08-05GOLDMAN SACHS GROUP INCSell753$21.9716.54K
2026-08-05GOLDMAN SACHS GROUP INCSell672$22.0214.80K
2026-08-05GOLDMAN SACHS GROUP INCSell6.97K$22.03153.55K
2026-08-05GOLDMAN SACHS GROUP INCSell400$22.028.81K
2026-08-05GOLDMAN SACHS GROUP INCSell1.18K$21.8425.77K
2026-08-05GOLDMAN SACHS GROUP INCSell1.04K$22.0522.93K
2026-08-05GOLDMAN SACHS GROUP INCSell300$20.846.25K
2026-08-05GOLDMAN SACHS GROUP INCSell443$21.789.65K
2026-08-05GOLDMAN SACHS GROUP INCSell200$22.054.41K
2026-08-05GOLDMAN SACHS GROUP INCSell700$22.0715.45K
2026-08-05GOLDMAN SACHS GROUP INCSell1.16K$22.1925.81K
2026-08-05GOLDMAN SACHS GROUP INCSell100$21.992.20K

Institutional holders

HolderSharesChangeChange %Value
No data yet.

Earnings and financials

Attovia Therapeutics, Inc. (ATTO) trades at $15.10, with a market cap of $689.14M and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Attovia Therapeutics (ATTO) Financials: Revenue & Earnings

ATTO$15.10+0.10 +0.64%

$689.14M

Market Cap

—

P/E

—

Forward P/E

—

Score

Price History